Cravath, Latham Steer J&J's $6.5B Momenta Buy
By McCord Pagan ( August 19, 2020, 11:04 AM EDT) -- Johnson & Johnson and Momenta announced Wednesday that the consumer products and drug manufacturer will buy the rare disease research and biotechnology company in a $6.5 billion deal guided by Cravath and Latham & Watkins....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.